AERI
Aerie Pharmaceuticals Inc
Price:  
15.25 
USD
Volume:  
1,206,402.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aerie WACC - Weighted Average Cost of Capital

The WACC of Aerie Pharmaceuticals Inc (AERI) is 7.6%.

The Cost of Equity of Aerie Pharmaceuticals Inc (AERI) is 7.80%.
The Cost of Debt of Aerie Pharmaceuticals Inc (AERI) is 7.00%.

Range Selected
Cost of equity 6.80% - 8.80% 7.80%
Tax rate 0.50% - 1.00% 0.75%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.8% - 8.3% 7.6%
WACC

Aerie WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.69
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 8.80%
Tax rate 0.50% 1.00%
Debt/Equity ratio 0.31 0.31
Cost of debt 7.00% 7.00%
After-tax WACC 6.8% 8.3%
Selected WACC 7.6%